Trial intelligence / Profile preview

AEST for Ovarian Endometrioma

NCT05470972Phase 1Completed

Sponsor
Tanta University
Start
May 2020
Primary completion
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of ethanol in ovarian endometrioma, sponsored by Tanta University. Primary endpoint: Serum cytokines levels at 6 months. Started May 2020; status: completed.

02

Drugs

ethanol
03

Conditions

ovarian endometrioma

Beyond the preview

Go deeper on NCT05470972.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05470972.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call